MARKET IS CLOSED
Loading latest tickers...
Market Indices
S&P 500
$7,722.72
+0.73%
NASDAQ 100
$30,807.93
+1.00%
DOW JONES
$51,177.00
+0.49%
NASDAQ Composite
$27,190.86
+1.19%
RUSSELL 2000
$2,815.20
+0.90%
CBOE VIX
$15.31
-6.59%
Sector Heatmap
Technology+1.01%
Financials+0.06%
Healthcare-0.01%
Consumer Cycl+1.13%
Consumer Staples+0.25%
Energy+0.40%
Industrials+0.78%
Materials+0.66%
Real Estate+0.32%
Utilities+0.38%
Comm Services+0.35%
ARCT — Arcturus Therapeutics Holdings Inc. Common Stock
NasdaqArcturus Therapeutics Holdings Inc. Common Stock
$13.03
-0.18(-1.36%)
- O
- 13.33
- H
- 13.65
- L
- 12.79
- V
- 744.55K
⏱️ End-of-day dataAs of Oct 2, 2026
Chart
About ARCT
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on the development of infectious disease vaccines and opportunities within liver and respiratory rare diseases. It operates in one business segment, which includes all activities related to the discovery, development, and commercialization of messenger RNA medicines. The company's pipeline includes LUNAR-OTC and LUNAR-CF. Its Vaccine candidates include LUNAR-FLU, KOSTAIVE XBB.1.5, KOSTAIVE, and Others.
IndustryPHARMACEUTICAL PREPARATIONS
SectorNot available
IPO DateMay 22, 2013
Employees111
Stock ExchangeNasdaq
Ticker SymbolARCT
Websitehttps://www.arcturusrx.com
Key Financial Statistics
| Market Cap | $393.66M |
| P/E Ratio | N/A |
| Dividend Yield | N/A |
| EPS | N/A |
| Beta | N/A |
| 52-Week Range | $4.11 - $188.72 |
| 52-Week Avg Volume | 340.2K |
| VWAP | $13.01 |
| Transactions | 8,731 |
| Total Recorded Bars | 3,362 days |